Clinical Trial Update: Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options

View source ↗

Summary

Pfizer's Expanded Access Protocol for adults and pediatric patients with sickle cell disease who have no alternative treatment options is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Pfizer | Conditions: Sickle Cell Disease | Status: NO_LONGER_AVAILABLE